cancer screening guideline

(redirected from Prostate CA)

cancer screening guideline

Any guideline promulgated by an authoritative organisation (e.g., the American Cancer Society) for early detection of a malignancy which is common in a particular demographic, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival.

Cancer screening guidelines
• Breast CA—Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1–2 years thereafter, depending on risk factors. 
• Colorectal CA—Per NCI, Am. Cancer Society, and Am. College of Physicians: annual feacal occult blood test > age 40 and flexible sigmoidoscopy every 3–5 years > age 50.
• Prostate CA—Annual digital rectal examination after age 40, and measurement of PSA in serum. 
• Uterine cervix—Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the patient’s physician.

cancer screening guideline

Any guideline promulgated by an authoritative organization–eg Am Cancer Society, for early detection of a malignancy common in a particular population, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival. See Cancer screening, Cancer screening test; Cf Unproven methods for cancer management.
Cancer screening guidelines
Breast CA
Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1-2 years thereafter, depending on risk factors
Colorectal CA
Per NCI, Am Cancer Society, and Am College of Physicians–annual fecal occult blood test > age 40 and flexible sigmoidoscopy every 3-5 years > age 50 (NEJM 1991; 325:37)
Prostate CA
Annual digital rectal examination after age 40, and measurement of prostate-specific antigen or acid phosphatase in the serum
Uterine cervix
Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the Pt's physician
.
References in periodicals archive ?
VDR BsmI Prostate Ca BPH Male Control Genotypes N=23 n=25 n=18 BB 2 (8.
Main Outcome Measures: Prostate-specific antigen (PSA), I, and additional biomarkers of prostate CA status
Other prostate CA markers declined by 3 -19% and each of these changes also attained statistical significance (P values varying from 0.
Practice Implications: EGCG has inhibited prostate CA cells in vitro.
Hepatocyte growth factor (HGF)/c-Met signaling pathway is disturbed in a wide variety of cancers including prostate CA.
Other markers of prostate CA status or progression have also recently been found to either increase proliferation of CA cells or interfere with apoptosis.
In the latest report from a randomized trial, as indicated above, men assigned to FA had a significantly higher risk of becoming diagnosed with prostate CA compared with those given placebo.
The hospitals are Western Visayas Medical Center here contracted for breast cancer, acute lymphocytic leukemia and Low to Intermediate Risk Prostate CA and the Corazon Locsin Montelibano Memorial Regional Hospital in Bacolod City for Breast Cancer, Peritoneal Dialysis, Low to Intermediate Risk Prostate CA, acute lymphocytic leukemia and selected Orthopedic Implants.